|
Decision
Point 8
|
What laboratory monitoring, specific for the effects of low molecular weight heparin therapy, should be done?
a) Activated partial thromboplastin
time
b) Antithrombin
III activity
c) INR
d) Platelet
count
e) Anti-Xa
activity
